The primary objective in the biotechnology and pharmaceutical industry is to be the first market provider with a new therapeutic entity, the first to achieve maximum market penetration, and the first to create barriers to competition to be assured of freedom to operate.
Because the success of biotechnology companies today depends on their ability to transfer biotechnology and intellectual property rights for appropriate value, partnering relationships between pharmaceutical and biotechnology companies continue to increase. Licensing, with its flexibility and inclusion of provisions pertaining to improvements and patents, is uniquely suited to facilitate these transfers.
